More important now than ever, access to vaccines and medicines should not be the right of the rich and their countries only. Raffaella Ravinetto (Institute of Tropical Medicine) repeats the arguments for equitable access and to go way beyond the compulsory licensing of a few products in her article Towards a new structural approach to pharmaceutical innovation, intellectual property and public health: If not now, when? in the International Health Policies Newsletter.